Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
co-trimoxazol 960 mg/10 ml infusionsvæske til intravenøs anvendelse |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
anti-humant thymocytimmunglobulin fra heste 20 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
gammaglobulin fra heste 10 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing glyceryl trinitrate in parenteral dose form (medicinal product form) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing interferon alfa-n1 (medicinal product) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
testosteron til intramuskulær anvendelse |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Intravenous nutrition (amino acids) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Intravenous nutrition (carbohydrate) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
elektrolytter/sporstoffer til intravenøs ernæring |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Intravenous nutrition (fats) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Intravenous nutrition (ready mixed) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Intravenous nutrition (vitamins) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
isosorbiddinitrat til parenteral anvendelse |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocainhydrochlorid + adrenalin 2 %/1:80.000 cylinderampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocainhydrochlorid + glucose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing lidocaine and methylprednisolone (medicinal product) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing morphine in parenteral dose form (medicinal product form) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
muromonab-CD3 1 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Nifedipine-containing product in parenteral dose form |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing perfluorochemical (product) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing piperacillin and tazobactam (medicinal product) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Plasma protein solution |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
prilocainhydrochlorid 1 % injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
procainhydrochlorid 20 mg/ml (2 %) injektionsvæske, opløsning, hætteglas a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumchlorid 0,225 %/glucose 5 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocain 1,5 % injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bleomycin 2 mg/ml infusionsvæske, opløsning, hætteglas a 30 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bleomycin 2 mg/ml infusionsvæske, opløsning, hætteglas a 60 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
carboplatin 10 mg/ml infusionsvæske, opløsning, hætteglas a 180 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
carboplatin 10 mg/ml infusionsvæske, opløsning, hætteglas a 90 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cisplatin 1 mg/ml infusionsvæske, opløsning, hætteglas a 200 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kombinationspræparat med natriumlactat i halv styrke/glucose 5 %, infusionsvæske, opløsning i pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Ringer-laktat, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kombinationspræparat med natriumlactat i halv styrke, infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cyclophosphamid 20 mg/ml infusionsvæske, opløsning, hætteglas a 200 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cyclophosphamid 20 mg/ml infusionsvæske, opløsning, hætteglas a 100 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cyclophosphamid 20 mg/ml infusionsvæske, opløsning, hætteglas a 50 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Darrows infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dexstran 40/glucose 5 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Dextran 40 + natriumchlorid 0,9 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dextran 70 + glucose 5 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Dextran 70/natriumchlorid 0,9 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dopaminhydrochlorid i glucose 400 mg/250 ml infusionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
doxapramhydrochlorid 2 mg/ml infusionsvæske, opløsning, flaske a 500 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
doxorubicinhydrochlorid 150 mg/75 ml infusionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
doxorubicinhydrochlorid 2 mg/ml infusionsvæske, opløsning, hætteglas a 150 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 2 mg/ml infusionsvæske, opløsning, hætteglas a 100 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 2 mg/ml infusionsvæske, opløsning, hætteglas a 200 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
foscarnetnatrium 24 mg/ml infusionsvæske, opløsning, flaske a 250 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
gentamicin 800 µg/ml infusionsvæske, opløsning, hætteglas a 100 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
glucose 10 % infusionsvæske, opløsning, flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
glucose 15 % infusionsvæske, opløsning i flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
glucose 20 % infusionsvæske, opløsning i flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
glucose 40 % infusionsvæske, opløsning i flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
glucose 50 % infusionsvæske, opløsning i flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
glucose 5 % infusionsvæske, opløsning i flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
heparinnatrium 500 IE/natriumchlorid 0,9 % infusionsvæske, opløsning, flaske a 500 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
heparinnatrium 2000 IE/natriumchlorid 0,9 % infusionsvæske, opløsning, flaske a 1 l |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ifosfamid 80 mg/ml infusionsvæske, opløsning, hætteglas a 100 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ifosfamid 80 mg/ml infusionsvæske, opløsning, hætteglas a 50 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ifosfamid 80 mg/ml infusionsvæske, opløsning, hætteglas a 200 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Fruktose 10 % infusionsvæske, opløsning, flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,1 %/glucose 5 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,2 %/glucose 5 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,4 %/glucose 5 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,6 % + glucose 5 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
mannitol 10 % infusionsvæske, opløsning, flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
mannitol 20 % infusionsvæske, opløsning, flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
methotrexat 12,5 mg/ml infusionsvæske, opløsning, hætteglas a 30 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
methotrexat 12,5 mg/ml infusionsvæske, opløsning, hætteglas a 60 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
mitoxantron 2 mg/ml infusionsvæske, opløsning, hætteglas a 22,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
mitoxantron 2 mg/ml infusionsvæske, opløsning, hætteglas a 45 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/glucose 5 %/natriumchlorid 0,45 % infusionsvæske, opløsning, pose a 500 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 13,5 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 27 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 40 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 13,5 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 13,5 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 1 l |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 27 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 27 mmol + natriumchlorid 0,9 % infusionsvæske, opløsning i pose a 1 l |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 40 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/natriumklorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kaliumchlorid 40 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 1 l |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Ringers infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumhydrogencarbonat 4,2 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumhydrogencarbonat 8,4 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumchlorid 0,45 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumchlorid 0,18 %/glucose 10 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumchlorid 0,45 %/glucose 2,5 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumchlorid 0,45 % + glucose 5 % infusionsvæske, opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumklorid 0,9 %/glucose 5 % infusionsvæske opløsning, pose |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|